NP Life Sciences Health Industry Group Inc. (ACAT): key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023): $164.6K
Net Income/Loss (FY2023): -$2.9K
Total Assets (FY2023): $76.9K
Total Equity (FY2023): $16.4K
Cash Flows from Operating Activities (FY2023): -$73.6K

Source: NP Life Sciences Health Industry Group Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.

NP Life Sciences Health Industry Group Inc. (ACAT): key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023): $164.6K
Net Income/Loss (FY2023): -$2.9K
Total Assets (FY2023): $76.9K
Total Equity (FY2023): $16.4K
Cash Flows from Operating Activities (FY2023): -$73.6K

Source: NP Life Sciences Health Industry Group Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.